Utah Medical Products (NasdaqGS:UTMD) - Share price, News & Analysis

UTMD fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	0/6
Past Performance	5/6
Financial Health	6/6
Dividends	4/6

UTMD Stock Overview

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.

Rewards

Trading at 43.1% below our estimate of its fair value

Earnings grew by 43.2% over the past year

Risk Analysis

Significant insider selling over the past 3 months

Utah Medical Products Competitors

Merit Medical Systems

NasdaqGS:MMSI

US$3.5b

STERIS

NYSE:STE

US$23.5b

Mesa Laboratories

NasdaqGS:MLAB

US$1.1b

LeMaitre Vascular

NasdaqGM:LMAT

US$1.0b

Price History & Performance

Summary of all time highs, changes and price drops for Utah Medical Products
Historical stock prices
Current Share Price	US$84.90
52 Week High	US$133.87
52 Week Low	US$81.01
Beta	0.24
1 Month Change	-1.46%
3 Month Change	-8.58%
1 Year Change	-0.95%
3 Year Change	6.46%
5 Year Change	20.85%
Change since IPO	1,173.50%

Recent News & Updates

May 14

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend of US$0.29 per share on the 6th...

Shareholder Returns

	UTMD	US Medical Equipment	US Market
7D	1.6%	2.9%	6.2%
1Y	-0.9%	-14.9%	-11.4%

Return vs Industry: UTMD exceeded the US Medical Equipment industry which returned -14.9% over the past year.

Return vs Market: UTMD exceeded the US Market which returned -10.2% over the past year.

Price Volatility

Is UTMD's price volatile compared to industry and market?
UTMD volatility
UTMD Average Weekly Movement	3.1%
Medical Equipment Industry Average Movement	10.5%
Market Average Movement	7.8%
10% most volatile stocks in US Market	17.0%
10% least volatile stocks in US Market	2.8%

Stable Share Price: UTMD is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: UTMD's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1978	195	Kevin Cornwell	https://www.utahmed.com

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.

Utah Medical Products Fundamentals Summary

How do Utah Medical Products's earnings and revenue compare to its market cap?
UTMD fundamental statistics
Market Cap	US$309.46m
Earnings (TTM)	US$15.30m
Revenue (TTM)	US$50.41m

20.2x

P/E Ratio

6.1x

P/S Ratio

Is UTMD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
UTMD income statement (TTM)
Revenue	US$50.41m
Cost of Revenue	US$18.91m
Gross Profit	US$31.50m
Other Expenses	US$16.21m
Earnings	US$15.30m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	4.20
Gross Margin	62.49%
Net Profit Margin	30.35%
Debt/Equity Ratio	0%

How did UTMD perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

21%

Payout Ratio

Does UTMD pay a reliable dividends?

See UTMD dividend history and benchmarks

When do you need to buy UTMD by to receive an upcoming dividend?
Utah Medical Products dividend dates
Ex Dividend Date	Jun 16 2022
Dividend Pay Date	Jul 06 2022
Days until Ex dividend	18 days
Days until Dividend pay date	38 days

Does UTMD pay a reliable dividends?

See UTMD dividend history and benchmarks

Valuation

Is Utah Medical Products undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

43.1%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: UTMD ($84.9) is trading below our estimate of fair value ($149.1)

Significantly Below Fair Value: UTMD is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: UTMD is good value based on its Price-To-Earnings Ratio (20.2x) compared to the US Medical Equipment industry average (36.3x).

PE vs Market: UTMD is poor value based on its Price-To-Earnings Ratio (20.2x) compared to the US market (15.6x).

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: UTMD is overvalued based on its Price-To-Book Ratio (2.8x) compared to the US Medical Equipment industry average (2.5x).

Future Growth

How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

15.9%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Utah Medical Products performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

2.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: UTMD has high quality earnings.

Growing Profit Margin: UTMD's current net profit margins (30.3%) are higher than last year (25.3%).

Past Earnings Growth Analysis

Earnings Trend: UTMD's earnings have grown by 2.5% per year over the past 5 years.

Accelerating Growth: UTMD's earnings growth over the past year (43.2%) exceeds its 5-year average (2.5% per year).

Earnings vs Industry: UTMD earnings growth over the past year (43.2%) exceeded the Medical Equipment industry 16.1%.

Return on Equity

High ROE: UTMD's Return on Equity (14%) is considered low.

Financial Health

How is Utah Medical Products's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage

Financial Position Analysis

Short Term Liabilities: UTMD's short term assets ($79.5M) exceed its short term liabilities ($6.1M).

Long Term Liabilities: UTMD's short term assets ($79.5M) exceed its long term liabilities ($4.5M).

Debt to Equity History and Analysis

Debt Level: UTMD is debt free.

Reducing Debt: UTMD has not had any debt for past 5 years.

Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Dividend

What is Utah Medical Products's current dividend yield, its reliability and sustainability?

Dividend Score

3/6

Dividend Score 3/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

1.37%

Current Dividend Yield

Upcoming Dividend Payment

Dividend Yield vs Market

Notable Dividend: UTMD's dividend (1.37%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.49%).

High Dividend: UTMD's dividend (1.37%) is low compared to the top 25% of dividend payers in the US market (3.92%).

Stability and Growth of Payments

Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.

Growing Dividend: UTMD's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (20.5%), UTMD's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (21.2%), UTMD's dividend payments are well covered by cash flows.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

25.3yrs

Average board tenure

CEO

Kevin Cornwell (74 yo)

29.42yrs

Tenure

US$494,210

Compensation

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...

CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD494.21K) is below average for companies of similar size in the US market ($USD2.61M).

Compensation vs Earnings: Kevin's compensation has increased by more than 20% in the past year.

Board Members

Experienced Board: UTMD's board of directors are seasoned and experienced ( 25.3 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: UTMD insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/28 00:00
End of Day Share Price	2022/05/27 00:00
Earnings	2022/03/31
Annual Earnings	2021/12/31